These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30946085)

  • 61. "WATCH AND WAIT" STRATEGY IN RECTAL CANCER PATIENTS WITH A COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION THERAPY: A SINGLE-CENTER EXPERIENCE.
    Kokaine L; Radzina M; Liepa M; Gerina-Berzina A; Sīviņa E; Nikolajeva J; Gardovskis A; Gardovskis J; Miklaševičs E
    Exp Oncol; 2024 May; 46(1):53-60. PubMed ID: 38852052
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
    Hupkens BJP; Maas M; Martens MH; van der Sande ME; Lambregts DMJ; Breukink SO; Melenhorst J; Houwers JB; Hoff C; Sosef MN; Leijtens JWA; Berbee M; Beets-Tan RGH; Beets GL
    Ann Surg Oncol; 2018 Jan; 25(1):197-203. PubMed ID: 29134378
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
    Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
    Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 67. [A Case Report of Organ Preservation by Total Neoadjuvant Therapy and Local Excision for Lower Rectal Cancer].
    Imaoka H; Ieki H; Yamashita S; Ichikawa T; Uratani R; Shimura T; Kitajima T; Kawamura M; Yasuda H; Okugawa Y; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1866-1868. PubMed ID: 38303234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
    Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
    Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
    Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Short-term results and long-term oncologic outcomes between neoadjuvant chemoradiotherapy and adjuvant postoperative chemoradiotherapy for stage III rectal cancer: a case-matched study.
    Kang J; Jang SM; Baek JH; Lee WS; Cho TH
    Ann Surg Oncol; 2012 Aug; 19(8):2494-9. PubMed ID: 22476817
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
    Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
    Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer.
    Dizdarevic E; Frøstrup Hansen T; Pløen J; Henrik Jensen L; Lindebjerg J; Rafaelsen S; Jakobsen A; Appelt A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):556-563. PubMed ID: 31707122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-operative management in low-lying rectal cancers undergoing chemoradiation.
    Datta D; Engineer R; Saklani A; D'souza A; Baheti A; Kumar S; Krishnatry R; Ostwal V; Ramaswamy A; Patil P
    J Cancer Res Ther; 2024 Jan; 20(1):417-422. PubMed ID: 38554355
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
    van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
    Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
    Zhang Y; Sun Y; Xu Z; Chi P; Lu X
    Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oncologic Outcomes according to the Treatment Strategy in Radiologic Complete Responders after Neoadjuvant Chemoradiation for Rectal Cancer.
    Lee SY; Kim CH; Kim YJ; Kim HR
    Oncology; 2015; 89(6):311-8. PubMed ID: 26426305
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
    Glynne-Jones R; Hughes R
    Br J Surg; 2012 Jul; 99(7):897-909. PubMed ID: 22539154
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy.
    Lambregts DM; Maas M; Bakers FC; Cappendijk VC; Lammering G; Beets GL; Beets-Tan RG
    Dis Colon Rectum; 2011 Dec; 54(12):1521-8. PubMed ID: 22067180
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.